News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
539,024 Results
Type
Article (45705)
Company Profile (119)
Press Release (493192)
Multimedia
Podcasts (106)
Webinars (16)
Section
Business (145571)
Career Advice (2411)
Deals (28025)
Drug Delivery (123)
Drug Development (68370)
Employer Resources (153)
FDA (15793)
Job Trends (12022)
News (264962)
Policy (29808)
Tag
Academia (2309)
Academic (1)
Accelerated approval (15)
Adcomms (33)
Allergies (98)
Alliances (36274)
ALS (113)
Alzheimer's disease (1550)
Antibody-drug conjugate (ADC) (170)
Approvals (15751)
Artificial intelligence (321)
Autoimmune disease (35)
Automation (18)
Bankruptcy (312)
Best Places to Work (9202)
BIOSECURE Act (22)
Biosimilars (133)
Biotechnology (69)
Bladder cancer (103)
Brain cancer (38)
Breast cancer (359)
Cancer (2914)
Cardiovascular disease (243)
Career advice (2021)
Career pathing (33)
CAR-T (184)
CDC (43)
Cell therapy (511)
Cervical cancer (25)
Clinical research (56598)
Collaboration (956)
Company closure (4)
Compensation (778)
Complete response letters (43)
COVID-19 (2656)
CRISPR (63)
C-suite (359)
Cystic fibrosis (116)
Data (3040)
Decentralized trials (2)
Denatured (21)
Depression (81)
Diabetes (347)
Diagnostics (5347)
Digital health (19)
Diversity (5)
Diversity, equity & inclusion (43)
Drug discovery (131)
Drug pricing (161)
Drug shortages (33)
Duchenne muscular dystrophy (167)
Earnings (60667)
Editorial (51)
Employer branding (20)
Employer resources (138)
Events (78989)
Executive appointments (793)
FDA (17757)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (848)
Gene editing (136)
Generative AI (26)
Gene therapy (427)
GLP-1 (902)
Government (4061)
Grass and pollen (7)
Guidances (314)
Healthcare (14866)
HIV (41)
Huntington's disease (31)
IgA nephropathy (46)
Immunology and inflammation (191)
Immuno-oncology (17)
Indications (36)
Infectious disease (2842)
Inflammatory bowel disease (148)
Inflation Reduction Act (11)
Influenza (69)
Intellectual property (129)
Interviews (450)
IPO (14087)
IRA (56)
Job creations (3166)
Job search strategy (1669)
Kidney cancer (14)
Labor market (54)
Layoffs (570)
Leadership (27)
Legal (7000)
Liver cancer (79)
Longevity (10)
Lung cancer (404)
Lymphoma (214)
Machine learning (14)
Management (51)
Manufacturing (428)
MASH (106)
Medical device (11357)
Medtech (11365)
Mergers & acquisitions (14657)
Metabolic disorders (929)
Multiple sclerosis (92)
NASH (22)
Neurodegenerative disease (145)
Neuropsychiatric disorders (46)
Neuroscience (2281)
NextGen: Class of 2025 (4997)
Non-profit (3184)
Now hiring (23)
Obesity (484)
Opinion (244)
Ovarian cancer (95)
Pain (121)
Pancreatic cancer (127)
Parkinson's disease (191)
Partnered (19)
Patents (325)
Patient recruitment (194)
Peanut (48)
People (43306)
Pharmaceutical (33)
Pharmacy benefit managers (25)
Phase I (16958)
Phase II (24513)
Phase III (20080)
Pipeline (2154)
Policy (263)
Postmarket research (2208)
Preclinical (6934)
Press Release (31)
Prostate cancer (151)
Psychedelics (43)
Radiopharmaceuticals (220)
Rare diseases (525)
Real estate (4275)
Recruiting (61)
Regulatory (21604)
Reports (37)
Research institute (2068)
Resumes & cover letters (402)
Rett syndrome (9)
RNA editing (9)
RSV (57)
Schizophrenia (108)
Series A (150)
Series B (111)
Service/supplier (9)
Sickle cell disease (65)
Special edition (21)
Spinal muscular atrophy (131)
Sponsored (37)
Startups (2771)
State (1)
Stomach cancer (17)
Supply chain (80)
Tariffs (79)
The Weekly (84)
Vaccines (916)
Venture capital (61)
Weight loss (338)
Women's health (41)
Worklife (20)
Date
Today (104)
Last 7 days (515)
Last 30 days (2416)
Last 365 days (28881)
2025 (18379)
2024 (31447)
2023 (35036)
2022 (45111)
2021 (48538)
2020 (45562)
2019 (36243)
2018 (27424)
2017 (27840)
2016 (25833)
2015 (28007)
2014 (21815)
2013 (17835)
2012 (18995)
2011 (19432)
2010 (17561)
Location
Africa (677)
Alabama (52)
Alaska (6)
Arizona (185)
Arkansas (10)
Asia (31628)
Australia (5530)
California (7393)
Canada (1931)
China (586)
Colorado (299)
Connecticut (337)
Delaware (192)
Europe (77112)
Florida (1147)
Georgia (240)
Hawaii (3)
Idaho (38)
Illinois (558)
India (27)
Indiana (304)
Iowa (18)
Japan (220)
Kansas (92)
Kentucky (19)
Louisiana (12)
Maine (66)
Maryland (1025)
Massachusetts (5499)
Michigan (215)
Minnesota (416)
Mississippi (3)
Missouri (84)
Montana (12)
Nebraska (19)
Nevada (83)
New Hampshire (56)
New Jersey (2057)
New Mexico (14)
New York (1990)
North Carolina (1050)
North Dakota (8)
Northern California (3374)
Ohio (202)
Oklahoma (9)
Oregon (28)
Pennsylvania (1540)
Puerto Rico (11)
Rhode Island (25)
South America (1039)
South Carolina (37)
South Dakota (1)
Southern California (2810)
Tennessee (116)
Texas (1086)
United States (26789)
Utah (191)
Virginia (185)
Washington D.C. (69)
Washington State (603)
West Virginia (4)
Wisconsin (71)
539,024 Results for "transgene s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Transgene and BioInvent to Present Updated Data on Armed Oncolytic virus BT-001 at ESMO 2025
July 28, 2025
·
6 min read
Press Releases
Verinomics Introduces Transgene-Free Gene Editing and Genomic-Driven Accelerated Breeding Platforms for Specialty Crops
March 10, 2025
·
4 min read
Press Releases
Kraig Biocraft Laboratories Announces the Launch of Advanced Gene-Splicing Program and New Transgenics
April 16, 2025
·
3 min read
Transgene’s Combined General Meeting of May 5, 2023
The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held at 9:00 a.m. at the Company’s headquarters.
May 5, 2023
·
4 min read
Transgene Announces Upcoming January 2024 Investor Meetings
TRANSGENE announces that Management will participate in several investor events in the upcoming investor events, as set out below.
December 21, 2023
·
1 min read
Press Releases
Kraig Biocraft Laboratories Announces Breakthrough Transgenic Development Inspired by Darwin’s Bark Spider
January 8, 2025
·
3 min read
Press Releases
Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome
April 3, 2025
·
8 min read
Business
Transgene’s Board of Directors Proposes the Appointment of Carol Stuckley, MBA, as New Independent Director
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced that the Board of Directors has proposed Ms.
April 12, 2023
·
4 min read
Alzheimer’s disease
Biogen, Eisai’s Leqembi Slows Alzheimer’s Progression Through 4 Years of Treatment
Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the earlier stages of Alzheimer’s disease as compared to the condition’s natural progression.
July 30, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Scientists Behind Trial of Replimmune’s Tumor Destroyer Protest FDA’s Rejection
In an open letter, 22 experts who designed and ran Replimmune’s Phase III IGNYTE trial answered the FDA’s issues, as outlined in the complete response letter for the melanoma candidate RP1.
August 5, 2025
·
2 min read
·
Tristan Manalac
1 of 53,903
Next
